Spots Global Cancer Trial Database for Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Eribulin With Trastuzumab as First-line Therapy for Locally Recurrent or Metastatic HER2 Positive Breast Cancer
Official Title: A Phase 2, Multicenter, Single-Arm Study of Eribulin Mesylate With Trastuzumab as First-Line Therapy for Locally Recurrent or Metastatic Human Epidermal Growth Factor Receptor Two (HER2) Positive Breast Cancer
Study ID: NCT01269346
Conditions
Interventions
Study Description
Brief Summary: This is a multicenter phase 2 study designed to evaluate the safety and efficacy of eribulin mesylate in combination with trastuzumab as first line treatment in female subjects with locally recurrent or metastatic human epidermal growth factor receptor (HER2) positive breast cancer.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
University of Colorado, Denver, Colorado, United States
Florida Cancer Care, Davie, Florida, United States
Florida Oncology Associates, Jacksonville, Florida, United States
Ocala Oncology Center, Ocala, Florida, United States
Peachtree Hematology Oncology Associates, PC, Atlanta, Georgia, United States
Northwest Georgia Oncology Centers, P.C., Marietta, Georgia, United States
Montgomery Cancer Center, Mount Sterling, Kentucky, United States
Jackson Oncology Associates, PLLC, Jackson, Mississippi, United States
Heartland Regional Medical Center, Saint Joseph, Missouri, United States
Weill Cornell Breast Clinic, New York, New York, United States
Raleigh Hematology Associates, Raleigh, North Carolina, United States
Cancer Care of the Cascades, Bend, Oregon, United States
Medical Oncology Associates of Wyoming Valley, P.C., Kingston, Pennsylvania, United States
Charleston Hematology/Oncology, Charleston, South Carolina, United States
Medical University of South Carolina, Charleston, South Carolina, United States
C. Michael Jones, MD, Germantown, Tennessee, United States
Texas Oncology - Beaumont Marnie McFaddin Ward Cancer Center, Beaumont, Texas, United States
Texas Oncology - Medical City Dallas, Dallas, Texas, United States
Texas Oncology - El Paso Cancer Treatment Center Grandview, El Paso, Texas, United States
Texas Oncology - Memorial City, Houston, Texas, United States
Texas Oncology - McAllen South Second Street, McAllen, Texas, United States
Cancer Care Centers of South Texas, San Antonio, Texas, United States
Texas Oncology - Sherman, Sherman, Texas, United States
Texas Oncology - Sugar Land, Sugar Land, Texas, United States
Pensisula Cancer Institute, Newport News, Virginia, United States
Columbia Basin Hematology and Oncology, Kennewick, Washington, United States
Contact Details
Name: Sam Misir
Affiliation: Eisai Inc.
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
